Guggenheim lowered the firm’s price target on Endava (DAVA) to $40 from $45 and keeps a Buy rating on the shares. While delivering on fiscal Q1 expectations “appears achievable to us,” channel conversations suggest incremental budget adjustments by clients, which the firm thinks may pressure the high-end of Endava’s FY25 revenue growth outlook, the analyst tells investors in a preview.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava price target lowered to $27 from $30 at Citi
- Class Action Lawsuit Against Endava PLC (NYSE:DAVA)
- Endava price target lowered to $55 from $66 at Susquehanna
- Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
- Morning Movers: Darden rises following first quarter results